<p> Performance of Delayed-Enhancement MRI Using Gadoversetamide Contrast for the Detection and As- sessment of Myocardial Infarction: An International, Multicenter, Double-Blinded, Randomized Trial</p><p>Raymond J Kim, MD, Timothy SE Albert, MD, James H Wible, PhD, Michael D Elliott, MD, John C Allen, PhD, Jennifer C Lee, PhD, Michele Parker, RN, MS, Alicia Napoli, BS, Robert M Judd, PhD, for the Gadoversetamide Myocardial Infarction Imaging Investigators*</p><p>Duke Cardiovascular Magnetic Resonance Center (RJK, TSEA, MDE, MP, RMJ) Tyco Healthcare/Mallinckrodt, Inc (JHW, JCA, JCL, AN)</p><p>*The trial investigators are listed in the Appendix.</p><p>Head: Detection of Myocardial Infarction by MRI Word Count: 4286</p><p>Address for Correspondence Raymond J. Kim, MD, Duke Cardiovascular MRI Center, DUMC-3934, Durham, NC 27710. Phone: 919-668-3539 Fax: 919-668-3554 E-mail:[email protected] APPENDIX The following investigators participated in the study (number of enrolled patients): Aristobulo Ballestrini— Hospital Nacional, Buenos Aires, Argentina (1); Robert Biederman—Allegheny General Hospital, Pittsburg, PA (25); Yong Bradley—Brooke Army Medical Center, San Antonio, TX (4); Anthony DeMaria—UCSD Medical Center, San Diego, CA (1); Joel Fishman—Jackson Memorial Hospital, Miami, FL (9); Scott Flamm—St. Luke’s Episcopal Hospital, Houston, TX (58); Anthony Fuisz—Washington Hospital Center, Washington, DC (29); Luis Girotti—Hospital General de Agudos, Buenos Aires, Argentina (6); Antoinette Gomes—UCLA Medical Center, Los Angeles, CA (2); Frank Grothues—Otto von Guericke Universitat, Magdeburg, Germany (43); Ruben Kevorkian—Hospital General de Agudos, Buenos Aires, Argentina (11); Raymond Kim—Duke University Health System, Durham, NC (32); Christopher Kramer—University of Virginia Health System, Charlottesville, VA (27); Michael Lane—Methodist Hospital, San Antonio, TX (6); Massimo Lombardi—CNR Clinical Physiology Institute, Pisa, Italy (24); Edward Martin—Oklahoma Heart Institute, Tulsa OK (14); Osvaldo Masoli—Hospital General de Agudos, Buenos Aires, Argentina (36); Stefan Neubauer—University of Oxford, John Radcliffe Hospital, Oxford, UK (8); Dudley Pennell—Royal Brompton Hospital, London, UK (1); Frank Rademakers— University Hospital Gasthuisberg, Leuven, Belgium (9); Carlos Rochitte—University of Sao Paulo Heart Institute, InCor, Sao Paulo, Brazil (40); Markus Schwaiger—Nuklearmedizin Klinikum Universitat Munchen, Munich, Germany (31); Udo Sechtem—Robert Bosch Medical Center, Stuttgart, Germany (40); Pamela Woodard— Washington University Medical Center, St Louis, MO (55); Dipan Shah—Nashville Cardiovascular Magnetic Resonance Institute, Brentwood, TN (61); Albert van Rossum—VU Medical Center, Amsterdam, The Netherlands (27). </p><p>2</p>